Antibiotic treatment decreases exhaled nitric oxide levels in cystic fibrosis patients

B. Antus, E. Csiszer, I. Horvath (Budapest, Hungary)

Source: Annual Congress 2004 - Modern techniques bringing new insights into cystic fibrosis
Session: Modern techniques bringing new insights into cystic fibrosis
Session type: Thematic Poster Session
Number: 2387
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Antus, E. Csiszer, I. Horvath (Budapest, Hungary). Antibiotic treatment decreases exhaled nitric oxide levels in cystic fibrosis patients. Eur Respir J 2004; 24: Suppl. 48, 2387

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Glucocorticoid treatment reduces exhaled nitric oxide in cystic fibrosis patients
Source: Eur Respir J 2001; 17: 1267-1270
Year: 2001



Exhaled nitric oxide in stable adult cystic fibrosis patients, during exacerbation and following CFTR-modifying treatment
Source: Eur Respir J, 53 (5) 1802259; 10.1183/13993003.02259-2018
Year: 2019



Reduced exhaled nitric oxide in infants with cystic fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 384s
Year: 2004

Exhaled nitric oxide is not reduced in infants with cystic fibrosis
Source: Eur Respir J 2006; 27: 350-354
Year: 2006



Effect of inhaled L-arginine on airway nitric oxide in cystic fibrosis patients
Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle
Year: 2005


Fractional exhaled nitric oxide levels in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2016 – Asthma, bronchiectasis, and the risk factors for respiratory morbidity
Year: 2016


Airway nitric oxide production in patients with cystic fibrosis increases with ivacaftor therapy
Source: International Congress 2015 – Cystic fibrosis: assessment and treatment
Year: 2015


Differences in exhaled nitric oxide levels between patients with cystic fibrosis and atopic bronchial asthma
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013


The effect of inhaled steroids on exhaled nitric oxide levels in children with idiopathic bronchiectasis
Source: Eur Respir J 2001; 18: Suppl. 33, 181s
Year: 2001

Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments
Source: Eur Respir J 2009; 34: 117-124
Year: 2009



Airway acidification and exhaled nitric oxide in cystic fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 514s
Year: 2003

Orally and nasally exhaled nitric oxide and nitrite in asthmatic and cystic fibrosis patients
Source: Eur Respir J 2003; 22: Suppl. 45, 131s
Year: 2003

Bronchial and alveolar exhaled nitric oxide as a marker of systemic involvement in patients with Crohn‘s disease
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011


Nitric oxide production by the alveolar compartment of the lungs in cirrhotic patients
Source: Eur Respir J 2009; 34: 138-144
Year: 2009



Changes in nitric oxide production in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 190s
Year: 2006

An increase in exhaled nitric oxide is not associated with activity in pulmonary sarcoidosis
Source: Eur Respir J 2004; 24 : 609-614
Year: 2004



Exhaled nitric oxide predicts response to treatment in COPD patients with exacerbation
Source: Annual Congress 2008 - Phenotyping of asthma and COPD
Year: 2008


A 2-year follow-up of exhaled nitric oxide (FeNO) and pulmonary function tests in young patients with cystic fibrosis
Source: Eur Respir J 2001; 18: Suppl. 33, 538s
Year: 2001

Changes in nitric oxide production in patients with bronchial asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 588s
Year: 2007

Exhaled nitric oxide in patients with idiopathic pulmonary fibrosis and pulmonary hypertension
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008